SAKK 08/07: Docetaxel and cetuximab in patients with docetaxel-resistant hormone-refractory prostate cancer. A multicenter phase II trial. Immunohistochemical analysis of biomarkers

Research Project

 | 

01.01.2011

 - 30.06.2011